Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Risk Neuroblastoma Study 1 of SIOP-Europe (HRNBL1)
2006-001489-17Phase 3Completed
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Oct 2006
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Dinutuximab beta in neuroblastoma, sponsored by St. Anna Children's Cancer Research Institute. Primary endpoint: Event-free survival. Started Oct 2006; status: completed.
02
Drugs
Dinutuximab beta
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on 2006-001489-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001489-17.